| Pharmaceutical active ingredients: |
| Propranolol Hydrochloride |
| Available forms, composition and doses of Hopranolol: |
| N / A |
| Hopranolol medical category: |
| Human:Antimigraine preparationsBeta-adrenergic blocking agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C07AA05 - Propranolol |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Wellgo Pharmaceutical |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Half Inderal | Propranolol Hydrochloride | AstraZeneca |
| Half Inderal LA | Propranolol Hydrochloride | AstraZeneca |
| Hemipralon | Propranolol Hydrochloride | Beaufour Ipsen |
| Hemipralon LP | Propranolol Hydrochloride | Beaufour Ipsen |
| Hipranol | Propranolol Hydrochloride | CCM Duopharma BioTech; Zurich, South Africa |
| Huma-Pronol | Propranolol Hydrochloride | Humanpharma Gyogyszergyarto |
| Inderal | Propranolol Hydrochloride | AstraZeneca; Akrimax Pharmaceuticals; Cana; Four Star; Institute of Pharmaceutical Research and Technology; Nicholas Piramal; Teva; Wyeth; Zuellig Pharma |
| Inderal LA | Propranolol Hydrochloride | AstraZeneca; Akrimax Pharmaceuticals; Pfizer; Rouses Point Pharmaceuticals; Wyeth |
| Inderal Retard | Propranolol Hydrochloride | AstraZeneca |
| Inderalici | Propranolol Hydrochloride | AstraZeneca |